Enalaprilat: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: ACE inhibitor *Dosage Forms: *Routes of Administration: IV *Common Trade Names: Vasotec ==Adult Dosing== *1.25-5mg IV q6h *0.625 mg IV initially...") |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
| Line 7: | Line 7: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*1.25-5mg IV q6h | *1.25-5mg IV q6h | ||
*0. | *0.625mg IV initially, with repeated dose of 0.625mg if inadequate response for the following patients: | ||
**CrCl <30 | **CrCl <30 | ||
**Severe volume or salt depletion, recent HD, or concomitant diuretic use | **Severe volume or salt depletion, recent HD, or concomitant diuretic use | ||
Revision as of 10:28, 19 July 2016
Administration
- Type: ACE inhibitor
- Dosage Forms:
- Routes of Administration: IV
- Common Trade Names: Vasotec
Adult Dosing
- 1.25-5mg IV q6h
- 0.625mg IV initially, with repeated dose of 0.625mg if inadequate response for the following patients:
- CrCl <30
- Severe volume or salt depletion, recent HD, or concomitant diuretic use
- CHF
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk minimal
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
- Angioedema history (ACEi-induced, hereditary, or idiopathic)
Adverse Reactions
Serious
- Myocardial infarction
- Liver failure
- Angioedema
Common
- Hyperkalemia
- Nausea
- Headache
Pharmacology
- Half-life: ~11h
- Metabolism:
- Excretion: Renal. Dialyzable
Mechanism of Action
- Inhibits angiotensin converting enzyme, blocking conversion of angiotensin I to angiotensin II.